Humana Inc. (HUM) to Issue Quarterly Dividend of $0.89 on November 27th

Humana Inc. (NYSE:HUM) announced a quarterly dividend on Tuesday, September 1st. Shareholders of record on Friday, October 30th will be given a dividend of $0.8850 per share by the insurance provider on Friday, November 27th. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, October 30th.

Humana has increased its dividend by an average of 0.1% annually over the last three years. Humana has a payout ratio of 24.1% meaning its dividend is sufficiently covered by earnings. Research analysts expect Humana to earn $16.02 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 22.1%.

Humana Price Performance

Shares of HUM stock opened at $414.97 on Wednesday. Humana has a 12-month low of $163.11 and a 12-month high of $456.50. The firm has a fifty day moving average of $398.90 and a 200-day moving average of $306.65.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. The business’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same period in the previous year, the business posted $6.27 EPS. Equities analysts predict that Humana will post 9.03 EPS for the current fiscal year.

Analyst Ratings Changes

HUM has been the topic of several recent analyst reports. TD Cowen lifted their price objective on Humana from $350.00 to $370.00 and gave the company a “hold” rating in a report on Friday, July 31st. JPMorgan Chase & Co. upped their price target on shares of Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a report on Monday, August 10th. Truist Financial increased their price objective on shares of Humana from $415.00 to $475.00 and gave the stock a “hold” rating in a research report on Monday, October 12th. Zacks Research cut Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, Monness Crespi & Hardt raised Humana to a “buy” rating in a research note on Friday, October 9th. Twenty-one research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $453.30.

About Humana

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.